Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...
Streetwise Reports | January 3, 2020 |

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
Streetwise Reports | May 12, 2020 |

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....
Andrea Kramer | October 28, 2012 |

Cummins (CMI): Bullish bandwagon far from crowded

Engine issue Cummins Inc. ( NYSE: CMI , Stock Forum ) has been a broad-market standout, to say the least, besting its fellow S&P 500 Index (SPX) comrades with a gain of roughly 140% in 2010. What’s more, the equity has outperformed the SPX by almost 12% du...
Andrea Kramer | October 28, 2012 |

Chesapeake Energy (CHK): Can its stock continue to make new highs?

Chesapeake Energy Corp. ( NYSE: CHK , Stock Forum ) has embarked on a quest for new multi-year highs this week, after last night announcing a deal with CNOOC Ltd. ( NYSE: CEO , Stock Forum ). More specifically, the China-based firm said it will buy into several of Chesape...
Andrea Kramer | October 28, 2012 |

Beyond Meat, Nikola, Newlox: meat replacement, hydrogen, and green gold

The quest for a better world coupled with economic success motivates investors around the globe to participate in innovation and business ideas. These are often subjects that promote health and protect the environment. Those who think big and plan ahead receive the relevant at...
Mario Hose | September 30, 2020 |

The Company that’s taking Psychedelics from ‘Underground to Mainstream’

(Click image to play video) On a trip to Amsterdam, an item on many traveler’s agendas would be to indulge in some famed Dutch truffles. It is an experience to heighten the mind that Canadian public Company Red Light Holland Corp. (TRIP) ( CSE: T...
Dave Jackson | February 2, 2021 |

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...
Streetwise Reports | June 24, 2020 |
1 2 3 4 5 6 7 8 9 10